The Austen BioInnovation Institute in Akron (ABIA) is a unique collaboration of Akron Children’s Hospital, Akron General Health System, Northeastern Ohio Universities Colleges of Medicine and Pharmacy (NEOMED), Summa Health System and The University of Akron. The ABIA partnership is focused on patient-centered innovation and commercialization at the intersection of biomaterials and medicine.
This strategic alignment of institutional, state, federal and philanthropic support, accompanied with Akron’s rich legacy in industrial and materials science, is working to pioneer the next generation of life-enhancing and life-saving innovation that will transform Akron and the surrounding region into a model for biomedical discovery and enterprise. The aspiration is to be a global leader in discovering, developing and commercializing biomaterial solutions for patients with orthopaedic and wound healing problems, nationally distinct in improving health outcomes of the medically underserved, and nationally recognized for the use of simulation technologies to improve education of the healthcare team.
We are expanding ABIA’s footprint by pursuing mutually beneficial partnerships with organizations, institutions and companies across Ohio and the globe.
